Health Care
Price
$557.80
+3.76%Market Cap
$44B
Day High
$559.91
Day Low
$538.87
IDEXX Laboratories delivered strong Q1 FY2026 results with revenue of $1.14B (+14.3% YoY) and net income of $278.4M (+14.7% YoY), driven by expanding gross margins and solid operating cash flow generation.
Key risk: Current Ratio Near 1.0 Signals Liquidity Tightness
IDEXX's current ratio stands at approximately 1.12, meaning current assets only modestly exceed current liabilities of $1.30B. Current liabilities grew 14.4% YoY, faster than current assets (+10.4%), suggesting potential near-term liquidity pressure if business conditions deteriorate.
Other Health Care Equipment companies